Candel Therapeutics, Inc. (NASDAQ:CADL) on Wednesday revealed final survival data from a phase 2a trial of CAN-2409 in ...

Candel Therapeutics, Inc. (NASDAQ: CADL) shares are are trading lower Thursday after the company released final survival data from its phase 2a clinical trial of CAN-2409.

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass ...

Shares of Pliant Therapeutics PLRX have plunged 88.5% in the past three months following recent setbacks in the clinical ...

Telsey Advisory Group increased Dollar Tree, Inc. DLTR price target from $75 to $82. Telsey Advisory Group analyst Joseph ...

Charles Heidsieck has called on the expertise of Checkpoint Systems to deploy a complete RFID traceability solution.

Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, today announced it will present preclinical ...